×

Perivascular mesenchymal precursor cells

  • US 10,421,946 B2
  • Filed: 06/23/2015
  • Issued: 09/24/2019
  • Est. Priority Date: 03/28/2003
  • Status: Active Grant
First Claim
Patent Images

1. A therapeutic composition comprising a suspension of culture expanded mammalian mesenchymal precursor cells (MPCs), wherein the culture expanded cells are derived from adipose tissue cells that are multipotent and at least 1% of the culture expanded cells are positive for the surface marker 3G5 and one or both of the surface markers MUC18/CD146 and STRO-1.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×